“Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor”., Colomb Med, vol. 47, no. 4, pp. 196–202, Dec. 2016, doi: 10.25100/cm.v47i4.1989.